M&A Archives - Page 332 of 448

1 minute read

Novartis CEO Refutes Recent Report Of Weighing Options For Ophthalmology, Respiratory Units

January 10, 10:41 AM

Novartis AG (NYSE: NVS) said it would narrow its focus on five core therapeutic areas, including cardiovascular, immunology, neurodegenerative diseases, solid tumors, and hematology.

NVS

1 minute read

Wejo Group Limited Enters Into Business Combination With TKB Critical Technologies 1; Expected To Provide Up To $100M In Capital To Wejo

By Bill Haddad

January 10, 10:05 AM

Definitive Business Combination Agreement Expected to Provide up to $100 Million in Capital to Wejo and $11.25 per Share for TKB Shareholders Company to Provide a Business Update on Tuesday, January

USCT

5 minute read

Coinbase Discloses Restructuring Plan Amid Macro Headwinds, Pfizer Rebuts Generic Version Of COVID-19 Oral Treatment In China, Microsoft Mulls $10B Investment In ChatGPT Owner: Today’s Top Stories

By Vandana Singh

January 10, 9:17 AM

Benzinga Coinbase Bows Down To Macro Headwinds, To Let Go Of 950 Employees

AAPL

1 minute read

M&A
News

Accenture Announced Earlier It Will Acquire SKS Group; Terms Not Disclosed

By Charles Gross

January 10, 6:12 AM

Accenture (NYSE: ACN) has agreed to acquire SKS Group, a consulting firm that helps banks across Germany, Austria and Switzerland modernize their technology infrastructure and address regulatory requirements using SAP S/4HANA® solutions. Terms of the transaction were not disclosed.

ACN

1 minute read

Microsoft Announces Acquisition Of Fungible To Accelerate Datacenter Innovation; Fungible Will Join Co’s Datacenter Infrastructure Engineering Teams; No Financial Amount Mentioned

By Benzinga Newsdesk

January 9, 12:02 PM

- Reuters

MSFT

2 minute read

S&P Global Buys ChartIQ, Touts ‘Deeper Resources, Vast Library Of Financial Data’

By Renato Capelj

January 9, 10:24 AM

S&P Global Inc (NYSE: SPGI) recently acquired financial services charting provider ChartIQ.

SPGI

1 minute read

Medigus’ Subsidiary Eventer Technologies Signed A Definitive Agreement For Reverse Merger To Become A Public Company

By Benzinga Newsdesk

January 9, 9:56 AM

Medigus Ltd. (NASDAQ:MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that its 46.21% owned

MDGS

1 minute read

Coherus Agrees to Acquire Exclusive U.S. Commercial Rights To Eylea Biosimilar FYB203 From Klinge Biopharma; Terms Not Disclosed

By Benzinga Newsdesk

January 9, 9:20 AM

Coherus BioSciences, Inc. ((Coherus or Coherus BioSciences, NASDAQ:CHRS) announced today that it has executed a binding term sheet with Klinge Biopharma GmbH (Klinge Biopharma) for the exclusive commercialization rights

CHRS

1 minute read

M&A
News

CNBC’s David Faber Said Hearing Duck Creek, A Provider Of Intelligence Solutions For The Insurance Industry, Will Be Taken Private By Vista For $19 A Share (Roughly $2.6b) Vista To Announce Deal Shortly.

By Charles Gross

January 9, 8:24 AM

https://twitter.com/davidfaber/status/1612424310219591681

DCT

1 minute read

Ipsen To Acquire Albireo For $42.00/Share Plus A Contingent Value Right Of $10.00/Share

By Charles Gross

January 9, 6:10 AM

Ipsen (Euronext: IPN: ADR: IPSEY) and Albireo (Nasdaq: ALBO) today announced that they have entered into a definitive merger agreement under which Ipsen will acquire Albireo, a leading innovator in bile-acid modulators to treat pediatric and adult cholestatic liver diseases.

ALBO